MPLX

Mplx LP
D

MPLX

Arincen64/100B

Mplx LP stock forecast 2026–2030

Analysts' average 12-month price target for Mplx LP is 64.00, 14.5% above the current price of 55.89. Their targets range from 63.00 to 66.00.

Of the 12 firms that rated Mplx LP in the past 12 months, 7 rate it buy or strong buy, 5 hold and 0 sell or strong sell (each firm at its latest rating): a Buy consensus.

12-month price target
64.00 USD
+14.51%

Analysts' 1-year price targets range from 63.00 to 66.00, with an average of 64.00.

Past year
1-year forecast
Strong sellStrong buy
Buy
12 ratings
Buy
7
Hold
5
Sell
0

12-month price target

Highest target66.00
Average target64.00
Lowest target63.00
Current price55.89

Mplx LP price target history

Have analysts recently raised or lowered their Mplx LP price target and rating?

See how analysts moved their price target

How analysts rate Mplx LP, month by month

7 of 12 firms rate it buy now, against 5 of 7 in December 2025.

Buy Hold Sell

Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.

Month endBuyHoldSellFirms
Nov 202675012
Oct 202675012
Sept 202675012
Aug 202675012
Jul 202675012
Jun 202674011
May 202674011
Apr 202674011
Mar 202664010
Feb 20264408
Jan 20264307
Dec 20255207

Mplx LP analyst upgrades, downgrades and price targets

The latest rating change came on 29 July 2026, when Wolfe Research downgraded Mplx LP from Outperform to Peer Perform. The most recent new target came from RBC Capital on 21 August 2026: 64.00.

DateFirmRatingPrice targetChangePrice then
21 Aug 2026
RBC Capital
Elvira Scotto
Reiterated · Outperform60.00 → 64.00+6.7%58.40
12 Aug 2026
Morgan Stanley
Reiterated · Equal Weight60.00 → 66.00+10.0%59.79

Mplx LP EPS and revenue estimates

Analysts expect Mplx LP's EPS to grow 2.1% a year until 2028.

Analysts expect Mplx LP's revenue to grow 7.8% a year until 2028. Over the last 5 years it grew 7.1% a year, and over the last 3 years 3.9%.

Revenue

ReportedEstimate

EPS

ReportedEstimate
Fiscal yearEPSEPS growthEPS rangeRevenueRevenue growthRevenue rangeAnalysts
FY2028 (est.) 5.14+7.2%4.60 – 6.29 14.79B+5.2%13.88B – 15.88B8
FY2027 (est.) 4.79+12.0%4.31 – 5.09 14.06B+9.9%13.89B – 14.24B9
FY2026 (est.) 4.28-11.2%4.06 – 4.56 12.79B+2.0%12.31B – 13.06B8
FY2025 4.82+14.5%— 12.55B+14.6%——
FY2024 4.21+10.5%— 10.95B+1.8%——
FY2023 3.81+1.6%— 10.76B+2.1%——
FY2022 3.75—— 10.54B———

Does Mplx LP beat earnings estimates?

On average, analysts' EPS estimate was 9.4% off the result, either way, and their revenue estimate 7.4%, over the last 12 quarters.

EPS beats
23 / 56
Revenue beats
20 / 56
Average EPS surprise, last 12
+5.9%
Since
January 2013
QuarterReport dateEPS estimateReported EPSSurpriseRevenue estimateReported revenueSurprise
Q3 FY20263 Nov 20261.131.15+1.8%3.35B3.27B-2.5%
Q2 FY20264 Aug 20261.061.060.0%3.14B3.08B-1.9%
Q1 FY20265 May 20261.050.90-14.3%3.09B2.81B-9.3%
Q4 FY20253 Feb 20261.061.17+10.4%3.18B3.25B+2.4%
Q3 FY20254 Nov 20251.071.52+42.1%3.16B3.62B+14.6%
Q2 FY20255 Aug 20251.061.03-2.8%3.14B2.79B-11.2%
Q1 FY20256 May 20251.101.100.0%3.16B2.89B-8.8%
Q4 FY20244 Feb 20251.041.07+2.9%3.07B2.84B-7.6%
Q3 FY20245 Nov 20241.051.01-3.8%3.09B2.78B-10.2%
Q2 FY20246 Aug 20240.981.15+17.3%2.96B2.73B-7.7%
Q1 FY202430 Apr 20240.980.980.0%2.89B2.60B-10.0%
Q4 FY202330 Jan 20240.941.10+17.0%2.88B2.80B-2.6%

Mplx LP stock price 2026–2030: scenarios

If Mplx LP's earnings keep growing at the 2.1% a year analysts expect to FY2028, it would earn about 5.36 a share in FY2030. At the P/E it has traded at over the last five years (8.8 to 13.0) that is 46.95 to 69.84 a share, or 57.32 at its average P/E of 10.7. This is arithmetic on the analysts' estimates, not a prediction.

Bull Base Bear
Fiscal yearEPSBearBaseBull
FY2026 4.2837.5045.7955.78
FY2027 4.7941.9851.2662.46
FY2028 5.1444.9954.9466.93
FY2029 (extrapolated)5.2545.9656.1268.37
FY2030 (extrapolated)5.3646.9557.3269.84

Each year's EPS is the analysts' consensus to FY2028; the years after grow 2.1% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (8.8, 10.7, 13.0).

Is Mplx LP stock undervalued or overvalued?

Mplx LP's P/E of 13.0 is near the top of its 5-year range (8.2 to 13.4, median 11.0). It is within 5% of its 5-year high. Analysts do not expect faster growth than in recent years, so it is expensive compared with its own history. At its usual P/E (11.0 × EPS of 4.29), Mplx LP's fair value is 47.05; the price, 55.89, is ⁦18.8%⁩ above it. Its forward P/E, on the consensus for FY2026, is 13.1.

The price against its fair value
Fair value 47.05Price 55.8935.2357.49

Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (8.2 and 13.4). The price against its P/E range

Price to earnings ratio (TTM)
13.03
Five-year median P/E
10.97
Five-year P/E range
8.2 – 13.4
Forward P/E (FY2026)
13.05
PEG ratio
6.06
To the average target
+14.5%
See the full P/E history check Plus

Most undervalued US stocks

StockPriceFair valueUpside
99.090
194.93146Price 99.09244
+96.7%
42.225
82.9546Price 42.23165
+96.4%
186.680
360.82271Price 186.68451
+93.3%
213.670
405.57304Price 213.67507
+89.8%
161.160
305.51157Price 161.16396
+89.6%
160.650
300.09225Price 160.65375
+86.8%
165.860
308.95212Price 165.86442
+86.3%

Furthest below the fair value on each stock's page, updated every day.

Common questions about the Mplx LP stock forecast

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.